ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Co-administration of subtherapeutic doses of yohimbine and NaHS potentially ameliorates CKD-induced necroptosis by modulating RAAS/ROS imbalance, sympathetic overactivity, and inflammation.

Mahdi Hajiaqaei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.